Sciclone Pharmaceuticals, Inc. (SCLN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Diluted net income per share: 0.19
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Diluted net income per share: 0.19
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q2 EPS of $0.13, $0.03 better than the analyst estimate of $0.10. Revenue for the quarter came in at $33.1 million versus the consensus estimate of $33.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
